Coeliac disease

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Mooney, Peter D ^a   Hadjivassiliou, Marios ^a   Sanders, David S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY;

ANTIBODY DETECTION; CANCER RISK; CELIAC DISEASE; DIETARY COMPLIANCE; DISEASE ASSOCIATION; DUODENUM BIOPSY; ETHNICITY; EVIDENCE BASED MEDICINE; GLUTEN FREE DIET; HUMAN; NONHODGKIN LYMPHOMA; NONHUMAN; OSTEOPOROSIS; POPULATION RISK; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SEROLOGY; SEX DIFFERENCE; TREATMENT PLANNING; TREATMENT RESPONSE;

BIOPSY; CELIAC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIET, GLUTEN-FREE; DUODENUM; FOLLOW-UP STUDIES; HUMANS; PREVALENCE; WORLD HEALTH;

EID: 84896513079     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g1561     Document Type: Review

References (72)

1. Ludvigsson JF, Rubio-Tapia A, van Dyke CT, Melton LJ 3rd, Zinsmeister AR, Lahr BD, et al. Increasing incidence of celiac disease in a North American population. Am J Gastroenterol 2013;108:818-24.
2. Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010;42:587-95.
3. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp SL, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 2010;42:530-8.
4. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007;26:1217-25. (Pubitemid 47620425)
5. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137:88-93.
6. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001;120:636-51 (Pubitemid 32171637)
7. van Heel DA, West J. Recent advances in coeliac disease. Gut 2006;55:1037-46. (Pubitemid 43962618)
8. Kochhar R, Sachdev S, Kochhar R, Aggarwal A, Sharma V, Prasad KK, et al. Prevalence of coeliac disease in healthy blood donors: a study from north India. Dig Liver Dis 2012;44:530-2.
9. Wang XQ, Liu W, Xu CD, Mei H, Gao Y, Peng HM, et al. Celiac disease in children with diarrhea in 4 cities in China. J Pediatr Gastroenterol Nutr 2011;53:368-70.
10. Esteve M, Rosinach M, Fernandez-Banares F, Farre C, Salas A, Alsina M, et al. Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis. Gut 2006;55:1739-45. (Pubitemid 44893571)
11. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-92. (Pubitemid 36183856)
12. Rubio-Tapia A, Van Dyke CT, Lahr BD, Zinsmeister AR, El-Youssef M, Moore SB, et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 2008;6:983-7.
13. Hadithi M, von Blomberg BM, Crusius JB, Bloemena E, Kostense PJ, Meijer JW, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007;147:294-302. (Pubitemid 351664556)
14. Berti I, Della Vedova R, Paduano R, Devetta M, Caradonna M, Villanacci V, et al. Coeliac disease in primary care: evaluation of a case-finding strategy. Dig Liver Dis 2006;38:461-7. (Pubitemid 44382358)
15. Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: case finding study. BMJ 1999;318:164-7. (Pubitemid 29192607)
16. Mooney PD, Leeds JS, Libzo N, Sidhu R, Evans KE, Hall EJ, et al. Case-finding for coeliac disease in secondary care: A prospective multicentre UK study. Dig Liver Dis 2014;46:32-5.
17. van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010;303:1738-46.
18. Davidson LS, Fountain JR. Incidence of the sprue syndrome; with some observations on the natural history. BMJ 1950;1:1157-61.
19. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52.
20. McGowan KE, Castiglione DA, Butzner JD. The changing face of childhood celiac disease in north america: impact of serological testing. Pediatrics 2009;124:1572-8.
21. National Institute for Health and Clinical Excellence. Coeliac disease: recognition and assessment of coeliac disease. 2009. www.nice.org.uk/nicemedia/ pdf/CG86FullGuideline.pdf.
22. Ciclitira P, Dewar DH, McLaughlin SD, Sanders DS. The management of adults with coeliac disease. British Society of Gastroenterology, 2010. www.bsg.org.uk/images/stories/clinical/bsg-coeliac-10.pdf.
23. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of G. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-76; quiz 77.
24. Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol 2013;11:359-65e1.
25. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009;169:651-8.
26. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136-60.
27. Sanders DS, Hurlstone DP, Stokes RO, Rashid F, Milford-Ward A, Hadjivassiliou M, et al. Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J 2002;78:31-3. (Pubitemid 34074912)
28. Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol 2010;9:318-30.
29. Sainsbury A, Sanders DS, Ford AC. Meta-analysis: coeliac disease and hypertransaminasaemia. Aliment Pharmacol Ther 2011;34:33-40.
30. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol 2010;105:2520-4.
31. Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006;24:47-54. (Pubitemid 43894004)
32. Naiyer AJ, Hernandez L, Ciaccio EJ, Papadakis K, Manavalan JS, Bhagat G, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol 2009;43:225-32.
33. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010;31:73-81.
34. Korponay-Szabo IR, Szabados K, Pusztai J, Uhrin K, Ludmany E, Nemes E, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007;335:1244-7.
35. Mooney PD, Kurien M, Sanders DS. Simtomax, a novel point of care test for coeliac disease. Expert Opin Med Diagn 2013;7:645-5.
36. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94. (Pubitemid 30433773)
37. Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, Egner W, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 2008;6:314-20. (Pubitemid 351318379)
38. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011;106:508-14; quiz 15.
39. Carroccio A, Mansueto P, Iacono G, Soresi M, D'Alcamo A, Cavataio F, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012;107:1898-906; quiz 907.
40. Aziz I, Evans KE, Hopper AD, Smillie DM, Sanders DS. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharmacol Ther 2010;32:1392-7.
41. Rosinach M, Esteve M, Gonzalez C, Temino R, Marine M, Monzon H, et al. Lymphocytic duodenosis: aetiology and long-term response to specific treatment. Dig Liver Dis 2012;44:643-8.
42. Leffler D, Schuppan D, Pallav K, Najarian R, Goldsmith JD, Hansen J, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 2013;62:996-1004.
43. Evans KE, Aziz I, Cross SS, Sahota GR, Hopper AD, Hadjivassiliou M, et al. A prospective study of duodenal bulb biopsy in newly diagnosed and established adult celiac disease. Am J Gastroenterol 2011;106:1837-742.
44. Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M, et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007;334:729.
45. Biagi F, Andrealli A, Bianchi PI, Marchese A, Klersy C, Corazza GR. A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. Br J Nutr 2009;102:882-7.
46. Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009;30:315-30.
47. Sharkey LM, Corbett G, Currie E, Lee J, Sweeney N, Woodward JM. Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up. Aliment Pharmacol Ther 2013;38:1278-91.
48. Kaukinen K, Sulkanen S, Maki M, Collin P. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 2002;14:311-5. (Pubitemid 34259282)
49. Rubio-Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut 2010;59:547-57.
50. Logan RF. Malignancy in unrecognised coeliac disease: a nail in the coffin for mass screening? Gut 2009;58:618-9.
51. Cooper BT, Holmes GK, Cooke WT. Lymphoma risk in coeliac disease of later life. Digestion 1982;23:89-92. (Pubitemid 12161382)
52. Gough KR, Read AE, Naish JM. Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut 1962;3:232-9.
53. Harris OD, Cooke WT, Thompson H, Waterhouse JA. Malignancy in adult coeliac disease and idiopathic steatorrhoea. Am J Med 1967;42:899-912.
54. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989;30:333-8. (Pubitemid 19091159)
55. Holmes GK, Stokes PL, Sorahan TM, Prior P, Waterhouse JA, Cooke WT. Coeliac disease, gluten-free diet, and malignancy. Gut 1976;17:612-9.
56. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004;20:769-75. (Pubitemid 39319232)
57. Olen O, Askling J, Ludvigsson JF, Hildebrand H, Ekbom A, Smedby KE. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis 2011;43:862-8.
58. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 2004;329:716-9.
59. Kane EV, Newton R, Roman E. Non-Hodgkin lymphoma and gluten-sensitive enteropathy: estimate of risk using meta-analyses. Cancer Causes Control 2011;22:1435-44.
60. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803. (Pubitemid 30106610)
61. Novakovic BJ, Novakovic S, Frkovic-Grazio S. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas. Oncol Rep 2006;16:191-5.
62. Lebwohl B, Granath F, Ekbom A, Smedby KE, Murray JA, Neugut AI, et al. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med 2013;159:169-75.
63. Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med 2003;115:191-5. (Pubitemid 37338143)
64. Silano M, Volta U, Vincenzi AD, Dessi M, Vincenzi MD, Collaborating Centers of the Italian Registry of the Complications of Coeliac D. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci 2008;53:972-6. (Pubitemid 351379816)
65. Meyer D, Stavropolous S, Diamond B, Shane E, Green PH. Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol 2001;96:112-9. (Pubitemid 32104817)
66. Passananti V, Santonicola A, Bucci C, Andreozzi P, Ranaudo A, Di Giacomo DV, et al. Bone mass in women with celiac disease: role of exercise and gluten-free diet. Dig Liver Dis 2012;44:379-83.
67. Bianchi ML, Bardella MT. Bone in celiac disease. Osteoporos Int 2008;19:1705-16.
68. Corazza GR, Di Sario A, Cecchetti L, Jorizzo RA, Di Stefano M, Minguzzi L, et al. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone 1996;18:525-30. (Pubitemid 26257872)
69. Ludvigsson JF, Olen O, Bell M, Ekbom A, Montgomery SM. Coeliac disease and risk of sepsis. Gut 2008;57:1074-80.
70. Barratt SM, Leeds JS, Sanders DS. Quality of life in coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointestin Liver Dis 2011;20:241-5.
71. Hallert C, Lohiniemi S. Quality of life of celiac patients living on a gluten-free diet. Nutrition 1999;15:795-7. (Pubitemid 29461031)
72. Barratt SM, Leeds JS, Robinson K, Shah PJ, Lobo AJ, McAlindon ME, et al. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011;23:159-65.